Cosciens Biopharma Stock Analysis
| CSCI Stock | 3.13 0.04 1.29% |
COSCIENS Biopharma is overvalued with Real Value of 2.83 and Hype Value of 3.16. The main objective of COSCIENS Biopharma stock analysis is to determine its intrinsic value, which is an estimate of what COSCIENS Biopharma is worth, separate from its market price. There are two main types of COSCIENS Biopharma's stock analysis: fundamental analysis and technical analysis.
The COSCIENS Biopharma stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and COSCIENS Biopharma's ongoing operational relationships across important fundamental and technical indicators.
COSCIENS |
COSCIENS Stock Analysis Notes
The company has price-to-book (P/B) ratio of 0.49. Some equities with similar Price to Book (P/B) outperform the market in the long run. COSCIENS Biopharma recorded a loss per share of 2.69. The entity had not issued any dividends in recent years. The firm had 1:4 split on the 3rd of May 2024. For more info on COSCIENS Biopharma go to https://www.cosciensbio.com.COSCIENS Biopharma Quarterly Total Revenue |
|
COSCIENS Biopharma Investment Alerts
| COSCIENS Biopharma generated a negative expected return over the last 90 days | |
| COSCIENS Biopharma was previously known as Aeterna Zentaris and was traded on NASDAQ Exchange under the symbol AEZS. | |
| The company reported the previous year's revenue of 7.26 M. Net Loss for the year was (3.55 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| COSCIENS Biopharma generates negative cash flow from operations | |
| Latest headline from globenewswire.com: COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs |
COSCIENS Largest EPS Surprises
Earnings surprises can significantly impact COSCIENS Biopharma's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-03-27 | 2023-12-31 | -3.88 | -4.64 | -0.76 | 19 | ||
2023-05-09 | 2023-03-31 | -4.28 | -3.52 | 0.76 | 17 | ||
2023-11-09 | 2023-09-30 | -2.44 | -3.4 | -0.96 | 39 |
COSCIENS Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.08 M.Management Efficiency
COSCIENS Biopharma has return on total asset (ROA) of (0.2334) % which means that it has lost $0.2334 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6592) %, meaning that it created substantial loss on money invested by shareholders. COSCIENS Biopharma's management efficiency ratios could be used to measure how well COSCIENS Biopharma manages its routine affairs as well as how well it operates its assets and liabilities. As of now, COSCIENS Biopharma's Total Assets are increasing as compared to previous years. The COSCIENS Biopharma's current Total Current Assets is estimated to increase to about 15.6 M, while Non Current Assets Total are projected to decrease to under 14.5 M.COSCIENS Biopharma showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Operating Margin (1.61) | Beta 2.274 | Return On Assets (0.23) | Return On Equity (0.66) |
Technical Drivers
As of the 30th of November, COSCIENS Biopharma shows the risk adjusted performance of (0.05), and Mean Deviation of 2.09. COSCIENS Biopharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.COSCIENS Biopharma Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. COSCIENS Biopharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for COSCIENS Biopharma. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
COSCIENS Biopharma Predictive Daily Indicators
COSCIENS Biopharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of COSCIENS Biopharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
COSCIENS Biopharma Forecast Models
COSCIENS Biopharma's time-series forecasting models are one of many COSCIENS Biopharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary COSCIENS Biopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About COSCIENS Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how COSCIENS Biopharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling COSCIENS shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as COSCIENS Biopharma. By using and applying COSCIENS Stock analysis, traders can create a robust methodology for identifying COSCIENS entry and exit points for their positions.
COSCIENS Biopharma is entity of United States. It is traded as Stock on NASDAQ exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding COSCIENS Biopharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio File Import Now
Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format |
| All Next | Launch Module |
Complementary Tools for COSCIENS Stock analysis
When running COSCIENS Biopharma's price analysis, check to measure COSCIENS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COSCIENS Biopharma is operating at the current time. Most of COSCIENS Biopharma's value examination focuses on studying past and present price action to predict the probability of COSCIENS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COSCIENS Biopharma's price. Additionally, you may evaluate how the addition of COSCIENS Biopharma to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |